| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.003 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.098 | 0.003 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.091 | 0.004 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.095 | 0.005 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |